# N-cadherin mimetic hydrogels drive superior regenerative and paracrine responses in 3D cultures of adipose-derived mesenchymal stem cells

**Authors:** Demet KAÇAROĞLU, Alper Murat ULAŞLI, Aybüke Didenur SAK, Seher YAYLACI

PMC · DOI: 10.55730/1300-0152.2738 · Turkish Journal of Biology · 2025-02-03

## TL;DR

This study shows that culturing stem cells in a 3D N-cadherin mimetic environment improves their regenerative abilities and paracrine signaling, which could enhance tissue repair.

## Contribution

The novel contribution is demonstrating that N-cadherin mimetic hydrogels enhance stem cell viability, reduce apoptosis, and boost growth factor secretion more effectively than traditional 2D or 3D spheroid cultures.

## Key findings

- 3D N-cadherin mimetic cultures increased stem cell viability and reduced apoptosis compared to 2D cultures.
- The 3D N-cadherin environment upregulated genes related to tissue remodeling and increased growth factor secretion.
- Conditioned media from these cultures improved endothelial cell viability and migration.

## Abstract

Cadherin-based biomaterials play a pivotal role in influencing the fate of mesenchymal stem cells (MSC). Enhancing the adhesion of adipose tissue-derived MSCs has been shown to augment their paracrine effects while N-cadherin biomaterials have been suggested to regulate the paracrine effects of MSCs via specific growth factors although the precise mechanisms underlying this regulation remain insufficiently understood. This study aims to compare the effects of a 3D N-cadherin mimetic environment on cell viability, apoptosis, extracellular matrix regulation, and growth factor expression with those observed in traditional 2D and 3D spheroid cultures. Additionally, the study seeks to evaluate the effects of conditioned media derived from the N-cadherin mimetic environment on the viability and migration of endothelial cells.

Peptide hydrogels, including HAVDI and SCRAM, were used as N-cadherin mimetics at a concentration of 1 mM, and four experimental groups were established: 2D classical culture, 3D spheroid culture, 3D HAVDI, and 3D SCRAM. Cell viability was assessed using the MTT assay, while gene expression analysis (BCL-XL, BCL-2, BAX, MMP-9, TIMP1, MMP-2, PLAU, HGF, FGF, and VEGFR2) was performed via qRT-PCR. Secretion levels of growth factors (PDGF-BB, FGF-2, and VEGF-A) were quantified using ELISA. The effects of conditioned media on the proliferation and migration of human umbilical vein endothelial cells were evaluated through MTT assays, calcein staining, and wound healing assays.

In the 3D HAVDI group, where MSCs were cultured in an N-cadherin mimetic peptide environment, cell viability increased, and apoptosis decreased. Moreover, this environment upregulated genes associated with tissue remodeling and increased the expression and secretion of growth factors, compared to the classical 2D culture. Additionally, treatment with conditioned media at 1:2 and 1:5 dilutions significantly improved the viability and migration potential of endothelial cells.

The N-cadherin mimetic peptide hydrogel represents a more effective culturing strategy than traditional 2D for enhancing the paracrine and regenerative properties of MSCs.

## Linked entities

- **Genes:** Bcl2l1 (BCL2-like 1) [NCBI Gene 12048], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], PLAU (plasminogen activator, urokinase) [NCBI Gene 5328], HGF (hepatocyte growth factor) [NCBI Gene 3082], FGF (fibroblast growth factor) [NCBI Gene 582058], KDR (kinase insert domain receptor) [NCBI Gene 3791]
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, PLAU (plasminogen activator, urokinase) [NCBI Gene 5328] {aka ATF, BDPLT5, QPD, UPA, URK, u-PA}, BCL2L1 (BCL2 like 1) [NCBI Gene 598] {aka BCL-XL/S, BCL2L, BCLX, Bcl-X, PPP1R52}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}
- **Chemicals:** MTT (MESH:C070243), HAVDI (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12068664/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12068664/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12068664/full.md

---
Source: https://tomesphere.com/paper/PMC12068664